Caricamento...
Clinical considerations for the development of biosimilars in oncology
Despite availability of biologic therapies, limited patient access to many of the most-effective cancer treatments affects overall health outcomes. To address this issue, many governments have enacted legislation for the approval of biosimilars. The term “biosimilar” refers to a biologic product tha...
Salvato in:
| Pubblicato in: | MAbs |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623533/ https://ncbi.nlm.nih.gov/pubmed/25621390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1008346 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|